NCT00466271View on ClinicalTrials.gov

Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Chronic Hepatitis CHepatic Fibrosis
Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00466271 - Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study | Biotech Hunter | Biotech Hunter